Biophytis (BPTSY) Competitors $1.80 0.00 (0.00%) As of 07/25/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock BPTSY vs. ADTX, JAGX, PTN, ENTO, APVO, SCNI, SXTP, ONCO, PTIX, and GRTXShould you be buying Biophytis stock or one of its competitors? The main competitors of Biophytis include Aditxt (ADTX), Jaguar Animal Health (JAGX), Palatin Technologies (PTN), Entero Therapeutics (ENTO), Aptevo Therapeutics (APVO), Scinai Immunotherapeutics (SCNI), 60 Degrees Pharmaceuticals (SXTP), Onconetix (ONCO), Atrinsic (PTIX), and Galera Therapeutics (GRTX). These companies are all part of the "pharmaceutical products" industry. Biophytis vs. Its Competitors Aditxt Jaguar Animal Health Palatin Technologies Entero Therapeutics Aptevo Therapeutics Scinai Immunotherapeutics 60 Degrees Pharmaceuticals Onconetix Atrinsic Galera Therapeutics Biophytis (NASDAQ:BPTSY) and Aditxt (NASDAQ:ADTX) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, dividends, analyst recommendations, valuation, earnings and media sentiment. Which has preferable earnings and valuation, BPTSY or ADTX? Biophytis has higher earnings, but lower revenue than Aditxt. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBiophytisN/AN/A-$18.43MN/AN/AAditxt$130K16.80-$34.45MN/AN/A Which has more risk & volatility, BPTSY or ADTX? Biophytis has a beta of 0.81, meaning that its share price is 19% less volatile than the S&P 500. Comparatively, Aditxt has a beta of 1.5, meaning that its share price is 50% more volatile than the S&P 500. Do insiders & institutionals have more ownership in BPTSY or ADTX? 0.1% of Biophytis shares are owned by institutional investors. Comparatively, 15.5% of Aditxt shares are owned by institutional investors. 3.7% of Biophytis shares are owned by company insiders. Comparatively, 0.0% of Aditxt shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Does the media prefer BPTSY or ADTX? In the previous week, Biophytis' average media sentiment score of 0.00 equaled Aditxt'saverage media sentiment score. Company Overall Sentiment Biophytis Neutral Aditxt Neutral Is BPTSY or ADTX more profitable? Biophytis has a net margin of 0.00% compared to Aditxt's net margin of -46,082.47%. Biophytis' return on equity of 0.00% beat Aditxt's return on equity.Company Net Margins Return on Equity Return on Assets BiophytisN/A N/A N/A Aditxt -46,082.47%-389.10%-84.71% SummaryBiophytis beats Aditxt on 5 of the 8 factors compared between the two stocks. Get Biophytis News Delivered to You Automatically Sign up to receive the latest news and ratings for BPTSY and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BPTSY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BPTSY vs. The Competition Export to ExcelMetricBiophytisPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$634K$763.52M$5.48B$9.51BDividend YieldN/A4.84%4.73%4.09%P/E RatioN/A1.3428.6723.80Price / SalesN/A25.20373.9066.58Price / CashN/A19.5635.4557.96Price / Book-0.116.778.275.55Net Income-$18.43M-$4.28M$3.24B$259.03M7 Day PerformanceN/A-4.26%-3.69%-4.59%1 Month Performance24.48%0.54%4.33%4.46%1 Year Performance-65.68%15.94%25.95%18.03% Biophytis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BPTSYBiophytisN/A$1.81flatN/AN/A$634KN/A0.0030ADTXAditxtN/A$1.24+5.1%N/A-100.0%$2.50M$130K0.0060Positive NewsGap UpJAGXJaguar Animal Health1.6825 of 5 stars$2.40-0.4%$60.00+2,400.0%-93.3%$2.45M$11.69M0.0050Positive NewsShort Interest ↑PTNPalatin TechnologiesN/A$0.09-44.6%N/AN/A$2.45M$350K-0.0630Gap DownHigh Trading VolumeENTOEntero TherapeuticsN/A$0.49+0.4%N/A-32.2%$2.35MN/A0.009Positive NewsShort Interest ↑Gap DownAPVOAptevo Therapeutics1.8857 of 5 stars$3.13+2.6%$219,040.00+6,997,983.1%-100.0%$2.31MN/A0.0050Positive NewsUpcoming EarningsSCNIScinai Immunotherapeutics1.2317 of 5 stars$2.32+5.5%N/A-65.1%$2.20M$660K-0.2420Positive NewsSXTP60 Degrees Pharmaceuticals1.9006 of 5 stars$1.33-4.3%$7.00+426.3%+93.5%$2.05M$300K-0.033Analyst ForecastShort Interest ↑ONCOOnconetix0.1374 of 5 stars$3.77-0.8%N/A-99.3%$2.02M$2.52M0.0012PTIXAtrinsic0.5918 of 5 stars$3.34+5.0%N/A-73.0%$1.87MN/A-0.252Gap UpGRTXGalera TherapeuticsN/A$0.02-3.1%N/A-80.8%$1.86MN/A-0.0730High Trading Volume Related Companies and Tools Related Companies Aditxt Alternatives Jaguar Animal Health Alternatives Palatin Technologies Alternatives Entero Therapeutics Alternatives Aptevo Therapeutics Alternatives Scinai Immunotherapeutics Alternatives 60 Degrees Pharmaceuticals Alternatives Onconetix Alternatives Atrinsic Alternatives Galera Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BPTSY) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biophytis S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biophytis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BPTSY Stock Alerts